CHOP/Penn Researchers: Fetal Signaling Pathways May Offer Future Targets for Treating Lung Injury
Published on in CHOP News
Published on in CHOP News
Specialized lung cells appear in the developing fetus much earlier than scientists previously thought. A new animal study reports how cells that become alveoli, the tiny compartments in which gas exchange occurs in the lung, begin their specialized roles very early in prenatal life. The researchers say that investigating the fetal signaling pathways active in this biological event may offer future opportunities to treat lung damage caused by prematurity and other lung injuries.
A research team from Children’s Hospital of Philadelphia (CHOP) and the Perelman School of Medicine at the University of Pennsylvania focused on the basic function of respiration — the exchange of oxygen and carbon dioxide within key cells, called alveolar type 1 and type 2 cells.
The same research team previously identified a new cell lineage in the lungs of mice and humans, which they called alveolar epithelial progenitor cells. The new research, published this week in PNAS, used single-cell RNA sequencing analysis, protein expression studies, and a new lineage-tracing tool to reveal details of early lung formation in a fetal mouse model.
“This cell specification begins remarkably early in lung development, and it progressively seeds the premature lung alveolus throughout the fetus’s gestation,” said first author David B. Frank, MD, PhD, a pediatric cardiologist at CHOP and a member of the Penn Center for Pulmonary Biology and the Penn Cardiovascular Institute.
Frank was a co-leader of this study, in collaboration with Edward E. Morrisey, PhD, Director of the Penn Center for Pulmonary Biology, and Rajan Jain, MD, an assistant professor of Cardiovascular Medicine at Penn.
The investigators are interested in deciphering the basics of how cells form their identity — essentially, why a cell becomes a lung cell as opposed to a heart cell. In particular, understanding how the lung forms is critical because many babies born prematurely have poorly formed organs. “What we found is that lung cells take on their intended fate much earlier than expected, which is a critical step toward being able to develop new therapeutics,” said Jain.
Alveolar cells share similar characteristics in both mice and humans: similar underlying genes, proteins and signaling systems, so the biological mechanisms found in the current study are considered relevant to how these cells function in humans, although follow-up research needs to further study those mechanisms.
The current study found that the specification of alveolar cells begins simultaneously with early lung formation, as cells in the developing embryo begin to move apart and branch out into specialized structures such as airways and alveoli. Many lung cells commit themselves to “cell fates,” their specialized roles, during branching morphogenesis, which occurs before the formation of the sac-shaped structure that becomes the lung alveolus.
“The early presence of these specialized alveolar cells may account for the fact that a minority of extremely premature human babies survive even with underdeveloped lungs,” said Frank. He added that because many other organ systems in addition to the pulmonary system remain underdeveloped in extremely premature infants, morbidity and mortality remain high in such cases.
The research team plans to further explore how their findings could eventually contribute to future treatments. Better understanding of lung development could lead to potential tools in regenerative medicine, perhaps by manipulating key signaling pathways or novel progenitor cell targets to grow new lung tissue after injury from prematurity or from acquired lung disease.
Funding for this study came from the National Institutes of Health (grants HL007915, HD043245, HL140129, HL110942, HL132999, HL129478, and HL134745), the Parker B. Francis Foundation, the Pulmonary Hypertension Association, Burroughs Wellcome, the National Science Foundation and the Gilead Research Scholars Foundation.
David B. Frank et al, “Early lineage specification defines alveolar epithelial ontogeny in the murine lung,” PNAS, Feb. 18, 2019.
Contact: The Children’s Hospital of Philadelphia,